… the JAK2-V617F mutation in patients with myelofibrosis. Using this novel technique, we
studied MRD kinetics in patients who underwent allogeneic stem cell transplantation after a dose-…

… symptoms in the majority of patients with myelofibrosis (MF). Therefore Rux, when given
prior to hematopoietic cell transplantation (HCT) in patients with MF was hypothesized to …

… outcome of patients with myelofibrosis undergoing curative … cell transplantation as part of
the continuum of myelofibrosis … system, MTSS myelofibrosis transplant scoring system, MRD …

… of patients who underwent allogeneic stem cell transplantation (HCT) for myelofibrosis with
… Sixty-one patients were identified who underwent HCT with one of these RIC regimens. …

… hematopoietic cell transplantation (HCT) is the only curative therapy for myelofibrosis (MF).
In … MF patients treated with allogeneic HCT (551 patients) and without HCT (non-HCT) (1377 …

… cell transplantation (alloHSCT) is the only curative treatment option in patients with
myelofibrosis, but is restricted to patients … and who can tolerate allogeneic transplantation. It is yet …

… Therapeutic management of patients with primary or secondary myelofibrosis (MF) … cell
transplantation (allo-HCT) remains heterogeneous. We retrospectively analyzed 216 patients …

… Algorithm for hematopoietic cell transplantation in patients with MF based on DIPSS score.
Platelet count, another parameter of the DIPSS Plus classification (in addition to karyotype …

… experience in the treatment of myelofibrosis contributed to this Position … patients with
myelofibrosis must have their spleen size assessed before allogeneic HCT. Myelofibrosis patients …

… cell transplantation (allo-SCT) in 57 patients with primary or post–essential
thrombocythemia/polycythemia vera myelofibrosis … patient with low risk, 5 patients with …